Eli Lilly and Company
ANTI-PACAP ANTIBODY
Last updated:
Abstract:
Antibodies to human pituitary adenylate cyclase-activating peptide, compositions comprising such antibodies, and methods of using such antibodies for the treatment of pain including headache and/or migraine.
Status:
Application
Type:
Utility
Filling date:
22 Nov 2019
Issue date:
30 Apr 2020